BridgeBio Pharma's Series C Round

BridgeBio Pharma raised a round of funding on September 13, 2017.

BridgeBio Pharma is a clinical-stage biotech company developing genetically-targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development…

Articles about BridgeBio Pharma's Series C Round: